Press Releases<< Back
Heart Transplant Patients And Cardiologists Concerned About Proposed Substantial Cut In Reimbursement Rate For Non-Invasive Testing To Manage Rejection Risk
See latest coverage of this story on
At a national telephonic press conference held this morning, Dr.
"We look forward to working with CMS to maintain the established AlloMap reimbursement rate and to demonstrate, after providing more facts and data, that an erroneous approach was used as the basis of the reduction, - comparing AlloMap to a non-related and different test," said
Davis continued: "If this proposed reduction remains unchanged after
The press conference represents initiatives by heart transplant patients and clinicians around the country to come together to call for the reversal of the CMS proposed reimbursement reduction.
AlloMap is a unique tool in heart transplant health care and is currently the only test produced and marketed by
Commenting further on the proposed reimbursement reduction,
AlloMap is now well-established as an effective monitoring tool in the care of heart transplant patients. The test is currently utilized in 110 of 130 transplant centers in the U.S. and received
The proposed Clinical Lab Fee Schedule (CLFS) for 2016 affects several other companies with well-established diagnostic tests. The schedule is subject to an open comment period through
Forward Looking Statements
This press release contains forward-looking statements including, but not limited to statements regarding the Company's expectations regarding the effect of possible CMS decisions on the Company's financial results and commercial operations. Forward looking statements are subject to uncertainties that could cause actual performance or results to differ materially from those expressed in the forward looking statements, including the Company's ability to enter new businesses or other geographies if it is forced to discontinue AlloMap testing in
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/heart-transplant-patients-and-cardiologists-concerned-about-proposed-substantial-cut-in-reimbursement-rate-for-non-invasive-testing-to-manage-rejection-risk-300156754.html
News Provided by Acquire Media